Total Payments
$335,644
2024 Payments
$23,545
Companies
31
Transactions
779
Medicare Patients
4,077
Medicare Billing
$4.1M
Payment Breakdown by Category
Other$241,628 (72.0%)
Travel$64,202 (19.1%)
Consulting$16,135 (4.8%)
Food & Beverage$12,777 (3.8%)
Education$901.92 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $241,628 | 101 | 72.0% |
| Travel and Lodging | $64,202 | 156 | 19.1% |
| Consulting Fee | $16,135 | 5 | 4.8% |
| Food and Beverage | $12,777 | 503 | 3.8% |
| Education | $901.92 | 14 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $109,417 | 166 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $98,918 | 117 | $0 (2024) |
| Amgen Inc. | $81,215 | 151 | $0 (2024) |
| PFIZER INC. | $27,044 | 82 | $0 (2024) |
| Astellas Pharma Global Development | $7,836 | 7 | $0 (2019) |
| Janssen Biotech, Inc. | $5,048 | 130 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $2,608 | 20 | $0 (2024) |
| Boston Scientific Corporation | $1,477 | 23 | $0 (2024) |
| Blue Earth Diagnostics Limited | $333.10 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $306.42 | 11 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23,545 | 63 | Astellas Pharma US Inc ($14,065) |
| 2023 | $75,608 | 105 | Dendreon Pharmaceuticals LLC ($56,347) |
| 2022 | $40,301 | 91 | Dendreon Pharmaceuticals LLC ($22,532) |
| 2021 | $22,276 | 87 | Dendreon Pharmaceuticals LLC ($11,659) |
| 2020 | $17,028 | 83 | Astellas Pharma US Inc ($15,006) |
| 2019 | $49,115 | 125 | Astellas Pharma US Inc ($21,138) |
| 2018 | $44,986 | 109 | Amgen Inc. ($22,017) |
| 2017 | $62,785 | 116 | Amgen Inc. ($36,341) |
All Payment Transactions
779 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $32.91 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/20/2024 | Myriad Genetic Laboratories, Inc. | BRACANALYSIS CDX (Device) | Food and Beverage | In-kind items and services | $88.44 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,550.00 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/14/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Travel and Lodging | Cash or cash equivalent | $794.95 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/14/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Travel and Lodging | Cash or cash equivalent | $159.85 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/14/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Travel and Lodging | Cash or cash equivalent | $95.18 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/14/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $78.55 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/11/2024 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 11/07/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: HORMONE THERAPY | ||||||
| 10/28/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: Oncology | ||||||
| 10/14/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,070.00 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/10/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $148.34 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA | Food and Beverage | In-kind items and services | $5.15 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Oncology | ||||||
| 08/21/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/20/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Oncology | ||||||
| 08/07/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $26.95 | General |
| Category: HORMONE THERAPY | ||||||
| 07/23/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Oncology | ||||||
| 07/18/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,129 | 13,471 | $4.0M | $1.1M |
| 2022 | 18 | 1,032 | 13,637 | $3.9M | $1.1M |
| 2021 | 18 | 817 | 10,774 | $2.6M | $729,976 |
| 2020 | 17 | 1,099 | 14,114 | $4.6M | $1.2M |
Total Patients
4,077
Total Services
51,996
Medicare Billing
$4.1M
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 47 | 1,702 | $1.7M | $448,142 | 26.0% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 51 | 1,723 | $590,989 | $154,888 | 26.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 51 | 7,320 | $314,760 | $134,343 | 42.7% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 41 | 41 | $217,264 | $58,490 | 26.9% |
| 55874 | Injection of biodegradable material next to prostate | Office | 2023 | 24 | 24 | $200,163 | $52,523 | 26.2% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 54 | 347 | $193,922 | $49,751 | 25.7% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 51 | 863 | $165,097 | $41,684 | 25.2% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2023 | 49 | 101 | $136,063 | $34,306 | 25.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 127 | 241 | $124,834 | $30,172 | 24.2% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 54 | 345 | $85,092 | $21,872 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 141 | 208 | $77,251 | $19,407 | 25.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 63 | 63 | $40,083 | $9,959 | 24.8% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 59 | 66 | $32,508 | $8,384 | 25.8% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 58 | 118 | $24,615 | $6,135 | 24.9% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 54 | 64 | $22,784 | $6,103 | 26.8% |
| 77470 | Special radiation treatment | Office | 2023 | 38 | 43 | $17,157 | $4,592 | 26.8% |
| 82272 | Stool analysis for blood, by peroxidase activity | Office | 2023 | 111 | 146 | $3,650 | $602.64 | 16.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 56 | 56 | $840.00 | $470.40 | 56.0% |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2022 | 43 | 1,585 | $1.7M | $455,628 | 26.8% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2022 | 44 | 1,605 | $572,985 | $153,092 | 26.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 57 | 8,040 | $345,720 | $136,737 | 39.6% |
| 55874 | Injection of biodegradable material next to prostate | Office | 2022 | 25 | 25 | $233,650 | $59,030 | 25.3% |
| 77301 | High precision radiation therapy planning | Office | 2022 | 36 | 36 | $192,744 | $51,707 | 26.8% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2022 | 46 | 329 | $183,582 | $49,147 | 26.8% |
| 77300 | Calculation of radiation therapy dose | Office | 2022 | 40 | 673 | $128,625 | $34,503 | 26.8% |
About Dr. Jim Hsiang, MD
Dr. Jim Hsiang, MD is a Specialist healthcare provider based in Corpus Christi, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164531273.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jim Hsiang, MD has received a total of $335,644 in payments from pharmaceutical and medical device companies, with $23,545 received in 2024. These payments were reported across 779 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($241,628).
As a Medicare-enrolled provider, Hsiang has provided services to 4,077 Medicare beneficiaries, totaling 51,996 services with total Medicare billing of $4.1M. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Radiation Oncology
- Location Corpus Christi, TX
- Active Since 08/30/2006
- Last Updated 01/17/2013
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1164531273
Products in Payments
- PROVENGE (Drug) $98,961
- XTANDI (Drug) $70,320
- Xtandi (Drug) $58,107
- XGEVA (Biological) $53,647
- Prolia (Biological) $22,909
- Erleada (Drug) $3,916
- ORGOVYX (Drug) $3,190
- Xofigo (Drug) $1,441
- SPACEOAR (Device) $1,233
- Nubeqa (Drug) $1,167
- ERLEADA (Drug) $1,122
- LYNPARZA (Drug) $288.25
- EVENITY (Biological) $275.28
- Axumin (Drug) $270.69
- KEYTRUDA (Biological) $211.24
- BRACANALYSIS CDX (Device) $146.22
- TrueBeam (Device) $106.78
- PLUVICTO (Drug) $103.80
- SpaceOAR VUE System - 10mL (Device) $96.10
- PreciseTumor (Device) $77.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Corpus Christi
Aftab Mahmood, M.d, M.D
Specialist — Payments: $45,641
Specialist $45,641
Dr. Gabriel Lopez, M.d, M.D
Specialist — Payments: $17,114
Specialist $17,114
Troy Creamean, Do, DO
Specialist — Payments: $10,616
Specialist $10,616
Garbine Goya, Md, MD
Specialist — Payments: $7,892
Specialist $7,892
Michael Nash, M.d, M.D
Specialist — Payments: $6,962
Specialist $6,962
Dr. Bruce Gibson, M.d, M.D
Specialist — Payments: $4,824
Specialist $4,824